Ahmed Aly, PhD
Assistant Professor
Department of Tropical Medicine
Tulane University School of Public Health and Tropical Medicine
J Bennett Johnston Bldg. Room 132
1324 Tulane Avenue
New Orleans, LA 70112
Phone: (504) 988-2286
Fax: (504) 988-7313

Aly Laboratory Website

Personal Statement:

My research is focusing on the biology and host-parasite interactions of the malaria parasite in the mosquito and the mammalian hosts. My ultimate research goals are to discover novel potent drug targeting and subunit vaccine candidates and the generation of effective and safe whole organism vaccines to help eradicate the malaria disease. I aim to use my expertise in Plasmodium targeting techniques in the generation of attenuated parasites as live vaccines and tailor-made transgenic Plasmodium parasite strains as tools to explore the functions of various Plasmodium proteins and their essential roles in the malaria parasite life cycle. I will use the rodent malaria parasite models and Anopheles mosquitoes to generate and study all life cycle stages of Plasmodium.


Research Interests:

Host-Parasite Interaction; Vaccine Development

Educational Background:

  • 2006 - 2010 Post Doctoral Fellow, Seattle Biomedical Research Institute, Seattle, USA.
  • 2005 PhD. (Dr. rer. nat.) Heidelberg University, Heidelberg, Germany.
  • 2001 M.Sc., Ulm University, Ulm, Germany.
  • 1995 B.Sc., Ain Shams University, Cairo, Egypt.

Professional Achievements:

  • Since 2015 - Member of the Editorial Board of the Nature group Journal of Scientific Reports.
  • Since 2015 - Member of the Malaria Review Panel for the US Department of Defense (DoD) Medical Research Program.
  • Since 2014 - Member of the Malaria Vaccine Review Panel for Military Infectious Diseases Research Program (MIDRP).
  • Since 2014 - Member of the ASTMH "Molecular Parasitology" Scientific Committee.
  • Since 2012 - Full Member, American Society of Tropical Medicine and Hygiene (ASTMH).


Honors, Awards and Patents:

  • 2015 - NIH-NIAID R21 Grant, Grant title: Selection of the Determinants of Plasmodium Sporozoite Infectivity and Motility.
  • 2015 - NIH-TNPRC Pilot Studies Grant, Grant title: DNA-Vaccination against Plasmodium Liver Stage Exported Proteins in Presence of Prior SIV Infection.
  • 2012 - Tulane COR Fellowship, Grant title: A Genetically-Attenuated Plasmodium Blood-Stage Vaccine that Protects Against Malaria.
  • 2008 - Listed as an inventor on US and Australians patents entitled "Live Genetically Attenuated Malaria Vaccines".
  • 2005 - Award for an outstanding presentation at the XVI International Molecular Parasitology Meeting, Woods Hole,  Massachusetts, USA.



  • Since 2013 - Established and taught all lectures of a 2 credit-hour courses entitled "Molecular Mechanisms of Pathogen Intervention" (TRMD 7300).
  • Since 2012 - Participated in teaching Malaria course (TRMD 7820).
  • 2013 - Participated in teaching Immunulogy course (TRMD 6170).

Selected Publications:

Groat‐Carmona, AM., Kain, H., Brownell, J., Douglass, AN., Aly, AS., & Kappe, SH. (2015). A Plasmodium α/β‐hydrolase modulates the development of invasive stages. Cellular microbiology.

Hart, RJ., Lawres, L., Fritzen, E., Mamoun, CB., & Aly, AS. (2014). Plasmodium yoelii Vitamin B5 Pantothenate Transporter Candidate is Essential for Parasite Transmission to the Mosquito. Scientific reports, 4.

Abu-Hashem, AA., & Aly, AS. (2012). Synthesis of new pyrazole, triazole, and thiazolidine-pyrimido [4, 5-b] quinoline derivatives with potential antitumor activity. Archives of pharmacal research, 35(3), 437-445.

MacKellar, DC., Vaughan, AM., Aly, AS., DeLeon, S., & Kappe, SH. (2011). A systematic analysis of the early transcribed membrane protein family throughout the life cycle of Plasmodium yoelii. Cellular microbiology, 13(11), 1755-1767.

Butler, NS., Schmidt, NW., Vaughan, AM., Aly, AS., Kappe, SH., & Harty, JT. (2011). Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasites. Cell host & microbe, 9(6), 451-462.

Aly AS, Lindner SE, Mackellar D, Peng X, SH Kappe SH. (2011). SAP1 is a critical posttranscriptional regulator of infectivity in malaria parasite sporozoite stages. Molecular Microbiology, 79(4), 929-39.

Butler NS, Schmidt NW, Vaughan AM, Aly AS, Kappe SH, Harty JT. (2011). Superior anti-malarial immunity after vaccination with late-liver-stage arresting genetically attenuated parasites. Cell Host and Microbe., 9(6), 451-62.

McKellar DC, Vaughan AM, Aly AS, DeLeon S, Kappe SH. (2011). A systematic analysis of the early transcribed membrane protein family throughout the life cycle of Plasmodium yoelii. Cellular Microbiology. 13(11), 1755–1767.

Aly AS, Downie MJ, Mamoun CB, Kappe SH. (2010). Sterile protection against lethal malaria by single subpatent immunization with a genetically attenuated blood stage vaccine. Cellular Microbiology, 12(7), 930-8.

Mackellar DC, O'Neill MT, Aly AS, Sacci JB Jr, Cowman AF, Kappe SH. (2010). Plasmodium falciparum PF10_0164 (ETRAMP10.3) is an essential parasitophorous vacuole and exported protein in blood stages. Eukaryot Cell, 9(5), 784-94.

Aly AS, Downie MJ, Mamoun CB, Kappe SH. (2010). Subpatent infection with nucleoside transporter 1-deficient Plasmodium blood stage parasites confers sterile protection against lethal malaria in mice. Cell Microbiol., 12(7), 930-8.

MacKellar DC, O'Neill MT, Aly AS, Cowman AF, Kappe SH. (2009). A putative Plasmodium falciparum UIS4 localizes to the parasitophorous vacuole but does not complement lack of UIS4 in the liver stage of Plasmodium yoelii. Eukaryotic Cell, 9(5), 784-94.

Vaughan AM, O'Neill MT, Tarun AS, Camargo N, Phuong TM,  Aly AS, Cowman AF, Kappe SH. (2009). Type II fatty acid synthesis is essential only for malaria parasite late liver stage development. Cellular Microbiology, 11(3), 506-20.

VanBuskirk KM, O'Neill MT, de La Vega P, Maier AG, Krzych U, Williams J, Dowler MG, Sacci JB, Kangwanrangsan N, Tsuboi T, Kneteman NM, Heppner DG, Murdock BA, Mikolajczak SA, Aly AS, Cowman AF, Kappe SH. (2009). Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design. PNAS, 106(31),13004-9.

Aly AS, Vaughan AM, Kappe SH. (2009). Malaria Parasite Development in the Mosquito and Infection of the Mammalian Host. Annual Review of Microbiology, 63, 195-221.

Vaughan AM, Aly AS, Kappe SH. (2008). Malaria parasite pre-erythrocytic stage infection: gliding and hiding. Cell Host and Microbe, 4(3), 209-18.

Mikolajczak SA, Silva-Rivera H, Peng X, Tarun AS, Camargo N, Jacobs-Lorena V, Daly TM, Bergman LW, de la Vega P, Williams J, Aly AS, Kappe SH. (2008). Distinct malaria parasite sporozoites reveal transcriptional changes that cause differential tissue infection competence in the mosquito vector and mammalian host. Molecular and Cellular Biology, 28(20), 6196-207.

Mikolajczak SA, Aly AS, Dumpit RF, Vaughan AM, Kappe SH. (2008). An efficient strategy for gene targeting and phenotypic assessment in the Plasmodium yoelii rodent malaria model. Molecular and Biochemical Parasitology, 158(2), 213-6.

Aly AS, Mikolajczak SA, Rivera HS, Camargo N, Jacobs-Lorena V, Labaied M, Coppens I, Kappe SH. (2008). Targeted deletion of SAP1 abolishes the expression of infectivity factors necessary for successful malaria parasite liver infection. Molecular Microbiology, 69(1), 152-63.

Mikolajczak SA, Aly AS, Kappe SH. (2007). Preerythrocytic malaria vaccine development. Current Opinion in Infectious Diseases.,20(5), 461-6.

Aly AS and K Matuschewski. (2005). A malarial cysteine protease is necessary for Plasmodium sporozoite egress from oocysts. Journal of Experimental Medicine, 202(2), 225-30.


Department of Tropical Medicine, 1440 Canal Street, Suite 2301, New Orleans, LA 70112, 504-988-3558